Study group | Inclusion criteria |
Control emmetropia (n = 25) | No previous disease history, BCVA ≥ 20/20, intraocular pressure ≥ 10 to ≤21 mmHg, no abnormalities on dilated fundus examination and OCT scan |
Control high myopia (n = 20) | Spherical equivalent refractive error of >−6.0 diopters or axial length > 26.5 mm |
Surgical treatment group (n = 46) | Stage 1-Eyes exhibiting Myopic Foveoschisis Stage 2-Eyes with evidence of Foveoetinal Detachment Stage 3-Eyes with evidence of a partial-or full-thickness macular hole Stage 4-Eyes with posterior pole rhegmatogenous retinal detachment associated with an macular hole |